BRIEF published on 02/12/2025 at 07:03, 1 year 4 months ago Carl Zeiss Meditec annonce une croissance modeste de son chiffre d'affaires pour le premier trimestre 2024/25 Carl Zeiss Meditec Croissance Des Revenus Ophtalmologie Premier Trimestre 2024/25 Performances Mondiales
PRESS RELEASE published on 02/12/2025 at 06:58, 1 year 4 months ago Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25 Carl Zeiss Meditec reports slight revenue growth of +3.2% in the first three months of fiscal year 2024/25, driven by order entry and order backlog recovery Revenue Growth Carl Zeiss Meditec Q1 Results 2024/25 Fiscal Year DORC Acquisition
BRIEF published on 12/11/2024 at 07:05, 1 year 6 months ago Carl Zeiss Meditec fait face à une baisse de son chiffre d'affaires au cours d'un exercice fiscal difficile Carl Zeiss Meditec Baisse Des Revenus Exercice 2023/24 Climat D’investissement Mondial Ophtalmologie Et Microchirurgie
BRIEF published on 12/11/2024 at 07:05, 1 year 6 months ago Carl Zeiss Meditec Faces Revenue Decline Amidst Challenging Fiscal Year Revenue Decline Carl Zeiss Meditec Fiscal Year 2023/24 Global Investment Climate Ophthalmology And Microsurgery
PRESS RELEASE published on 12/11/2024 at 07:00, 1 year 6 months ago Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved Carl Zeiss Meditec ends fiscal year 2023/24 with slight revenue decline but achieves adjusted EBIT forecast despite challenging economic conditions Revenue Decline Carl Zeiss Meditec Fiscal Year 2023/24 Adjusted EBIT Forecast Challenging Economic Conditions
BRIEF published on 08/06/2024 at 07:05, 1 year 10 months ago Carl Zeiss Meditec annonce une légère baisse de ses revenus pour les neuf premiers mois de 2023/24 Marge EBIT Baisse Des Revenus Ophtalmologie Performance Régionale Microchirurgie
BRIEF published on 08/06/2024 at 07:05, 1 year 10 months ago Carl Zeiss Meditec Reports Slight Revenue Decline for First Nine Months of 2023/24 EBIT Margin Revenue Decline Ophthalmology Regional Performance Microsurgery
PRESS RELEASE published on 08/06/2024 at 07:00, 1 year 10 months ago Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue Carl Zeiss Meditec AG reports slight decline in revenue for the first nine months of fiscal year 2023/24. EBIT and EBIT margin also decreased compared to the prior year Financial Performance EBIT EBIT Margin Revenue Decline Carl Zeiss Meditec AG
BRIEF published on 06/17/2024 at 10:14, 2 years ago Carl Zeiss Meditec AG révise ses prévisions de chiffre d'affaires et d'EBIT pour l'exercice 2023/24 EBIT Exercice 2023/24 Revenu Prévision Entreprise D’équipement
BRIEF published on 06/17/2024 at 10:14, 2 years ago Carl Zeiss Meditec AG Revises Revenue and EBIT Forecast for FY 2023/24 Revenue EBIT Forecast Equipment Business Fiscal Year 2023/24
Published on 06/26/2026 at 14:05, 3 hours 41 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 3 hours 46 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 4 hours 46 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 17:05, 41 minutes ago NAKIKI SE Receives an Adverse Opinion on Its 2024 Financial Statements and Management Report
Published on 06/26/2026 at 17:00, 46 minutes ago Darwin AG Announces Results of the 2026 Annual General Meeting
Published on 06/26/2026 at 16:38, 1 hour 8 minutes ago Cairn Homes Plc: Notice of H1 2026 Trading Update
Published on 06/26/2026 at 15:30, 2 hours 16 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 2 hours 22 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 07:00, 10 hours 46 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
